EUVIMEDEUVIMED entdecken
LeserbriefFallbericht

Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE

Mengtao Li, Yan Zhang, Nan Jiang, Chun Ning, Qian Wang, Dong Xu, Ziqian Wang, Lulu Lv, Daobin Zhou, Xiaofeng Zeng

New England Journal of Medicine · 2024

DOI: 10.1056/nejmc2403743 ↗

Kurz gefasst

Leserbrief in der Zeitschrift New England Journal of Medicine, 2024. Verfasst von Mengtao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Peking Union Medical College Hospital, Beijing, China. Hauptthemen laut MEDLINE: Antigens, CD19, Immunotherapy, Adoptive, Lupus Erythematosus, Systemic, Purpura, Thrombocytopenic, Idiopathic. Die Arbeit wurde bisher 75-mal zitiert (Crossref) und nennt 5 Literaturangaben. Gefördert von: Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park, Chinese Academy of Medical Sciences, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A woman with refractory thrombocytopenia complicating systemic lupus erythematosus had a response to CD19 CAR T cells with an increase in platelet counts and minimal symptoms of cytokine release syndrome.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antigens, CD19Immunotherapy, AdoptiveLupus Erythematosus, SystemicPurpura, Thrombocytopenic, IdiopathicAdultFemaleHumansReceptors, Chimeric AntigenT-Lymphocytes

Substanzen

Antigens, CD19Receptors, Chimeric Antigen

Autor:innen und Institutionen

  • Peking Union Medical College Hospital, Beijing, China.
  • Juventas Cell Therapy, Tianjin, China.
  • Peking Union Medical College Hospital, Beijing, China zhoudb@pumch.cn zengxfpumc@163.com.

Förderung

  • Beijing Municipal Science and Technology Commission, Adminitrative Commission of Zhongguancun Science Park
  • Chinese Academy of Medical Sciences
  • NIH HHS
  • Innovation and Technology Fund
  • CAMS Innovation Fund for Medical Sciences
  • National High Level Hospital Clinical Research Funding
  • Juventas Cell Therapy Ltd
  • Chinese National Key Technology R&D Program, Ministry of Science and Technology

Zitieren

APA

Li, M., Zhang, Y., Jiang, N., Ning, C., Wang, Q., Xu, D., Wang, Z., Lv, L., Zhou, D., & Zeng, X. (2024). Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE. New England Journal of Medicine. https://doi.org/10.1056/nejmc2403743

Vancouver

Li M, Zhang Y, Jiang N, Ning C, Wang Q, Xu D, et al. Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE. New England Journal of Medicine. 2024. doi:10.1056/nejmc2403743

BibTeX
@article{Li2024,
  author = {Li, Mengtao and Zhang, Yan and Jiang, Nan and Ning, Chun and Wang, Qian and Xu, Dong and Wang, Ziqian and Lv, Lulu and Zhou, Daobin and Zeng, Xiaofeng},
  title = {Anti–CD19 CAR T Cells in Refractory Immune Thrombocytopenia of SLE},
  journal = {New England Journal of Medicine},
  year = {2024},
  doi = {10.1056/nejmc2403743}
}
Kostenlos starten →